Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000146783 | SCV000194109 | benign | not specified | 2013-02-08 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000146783 | SCV000345339 | likely benign | not specified | 2016-09-20 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001697075 | SCV000714942 | benign | not provided | 2019-06-25 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003231187 | SCV002054855 | benign | Sotos syndrome | 2021-07-15 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001697075 | SCV002418054 | benign | not provided | 2025-01-05 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002453470 | SCV002738116 | likely benign | Inborn genetic diseases | 2017-06-14 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Breakthrough Genomics, |
RCV001697075 | SCV005222546 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV003891677 | SCV000314053 | benign | NSD1-related disorder | 2020-03-24 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |